Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5year results of a phase 2 trial

Bone ◽  
2012 ◽  
Vol 50 ◽  
pp. S47 ◽  
Author(s):  
B. Langdahl⁎ ◽  
N. Binkley ◽  
H. Bone ◽  
N. Gilchrist ◽  
H. Resch ◽  
...  
Keyword(s):  
Postmenopausal Women ◽  
Cathepsin K ◽  
Phase 2 ◽  
Cathepsin K Inhibitor ◽  
Phase 2 Trial

Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5year results of a phase 2 trial

Bone ◽  
2012 ◽  
Vol 51 (6) ◽  
pp. S12
Author(s):  
H. Resch ◽  
N. Binkley ◽  
H. Bone ◽  
J.A. Eisman ◽  
N. Gilchrist ◽  
...  
Keyword(s):  
Postmenopausal Women ◽  
Cathepsin K ◽  
Phase 2 ◽  
Cathepsin K Inhibitor ◽  
Phase 2 Trial

Treatment With the Cathepsin K Inhibitor Odanacatib in Postmenopausal Women With Low BMD: 5 Year Results of a Phase 2 Trial

2012 ◽  
Vol 15 (4) ◽  
pp. 497-498
Author(s):  
Nelson Watts ◽  
Neil Binkley ◽  
Henry Bone ◽  
Nigel Gilchrist ◽  
Bente Langdahl ◽  
...  
Keyword(s):  
Postmenopausal Women ◽  
Cathepsin K ◽  
Phase 2 ◽  
Cathepsin K Inhibitor ◽  
Phase 2 Trial

OP0248 Inhibition of Sclerostin with Romosozumab in Postmenopausal Women with Low Bone Mineral Density: Phase 2 Trial Results

2013 ◽  
Vol 72 (Suppl 3) ◽  
pp. A136.2-A137 ◽  
Author(s):  
M. R. McClung ◽  
A. Grauer ◽  
S. Boonen ◽  
J. P. Brown ◽  
A. Diez-Perez ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Phase 2 ◽  
Mineral Density ◽  
Low Bone Mineral Density ◽  
Phase 2 Trial

Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone Density

2009 ◽  
pp. 091029141139034-41 ◽  
Author(s):  
Henry G Bone ◽  
Michael R McClung ◽  
Christian Roux ◽  
Robert R Recker ◽  
John A Eisman ◽  
...  
Keyword(s):  
Bone Density ◽  
Postmenopausal Women ◽  
Cathepsin K ◽  
Cathepsin K Inhibitor ◽  
Low Bone Density
Sign in / Sign up

Export Citation Format

Share Document